All NHS trusts in England will be able to purchase InnerEye, a new artificial intelligence tool, for cost. The technology aids medical professionals in determining where therapeutic radiation beams should be directed to target malignant cells while protecting healthy ones.
A decade in the making, researchers at Addenbrooke’s Hospital trained the AI program with Microsoft.
Shortens the Duration of Radiotherapy
Doctors may now treat patients with head, neck, and prostate cancer thanks to the AI program’s two-and-a-half times faster processing speed than conventional techniques.
Addenbrooke’s received £500,000 from the NHS Artificial Intelligence Laboratory to pay for safety reviews and evaluations. A manufacturer is now receiving the program in exchange for agreeing to provide cloud-based technologies to other NHS trusts at cost.
- NHS trusts can buy the InnerEye AI tool for cost.
- Addenbrooke receives £500,000 from NHS for safety reviews.
- AI enhances diagnostics, early disease identification, and patient recovery.
Clinicians approve of the AI program’s work without corrections almost two-thirds of the time, and it is about 90% accurate.
Dr. Katharine Halliday, president of the Royal College of Radiologists, expressed optimism about the potential for AI to replace practices and procedures, such as cancer therapy and diagnostics.
AI has the potential to expedite the diagnostic process, assist physicians in identifying disease early, and provide patients with the greatest chance of recovery. But a clinical radiologist who has access to AI’s data, knowledge, and accuracy is a powerful asset in patient care.
While AI is very promising and can give a workforce that is under pressure more time, it cannot take the place of highly qualified and talented employees.
